Dry Eye Disease

“Culture eats strategy for breakfast.”

No need for an alarm clock on Feb. 15, at least in my house. My phone started blowing up around 0600 with the news: The prodigal son is back. Brent Saunders has returned to run Bausch + Lomb.

Brent Saunders has been appointed as CEO and chair of the board of directors at Bausch + Lomb, effective March 6, according to a company press release.

The FDA has accepted a new drug application for reproxalap, an investigational new drug candidate for signs and symptoms of dry eye disease, manufacturer Aldeyra Therapeutics announced in a press release.

We have come a long way in terms of identifying and treating dry eye before cataract procedures, as well as corneal pathology, but the lids are also crucial to accurate outcomes.

How were your holidays? This is kinda old news to be honest, seeing as how it was announced in a press release by the acquiring company just before Christmas.

In these videos, Preeya K. Gupta, MD, FACS, associate professor of ophthalmology at Duke University, talks about the various treatment options for dry eye, both approved and in the pipeline, as well as challenges in diagnosis.

In these videos, Preeya K. Gupta, MD, FACS, associate professor of ophthalmology at Duke University, talks about the various treatment options for dry eye, both approved and in the pipeline, as well as challenges in diagnosis.

In these videos, Preeya K. Gupta, MD, FACS, associate professor of ophthalmology at Duke University, talks about the various treatment options for dry eye, both approved and in the pipeline, as well as challenges in diagnosis.

In these videos, Preeya K. Gupta, MD, FACS, associate professor of ophthalmology at Duke University, talks about the various treatment options for dry eye, both approved and in the pipeline, as well as challenges in diagnosis.